Clinical trials
Phase 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital General de Mexico | 2 |
| PETHEMA Foundation | 2 |
| Chinese Academy of Medical Sciences | 1 |
| Kjeld Schmiegelow | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| National University Hospital, Singapore | 1 |
| Nordic Society for Pediatric Hematology and Oncology | 1 |
| Shandong University | 1 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
| Sun Yat-sen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 17 |
| Febrile Neutropenia | 1 |
| Hepatoblastoma | 1 |
| Immune System Diseases | 1 |
| Immunoproliferative Disorders | 1 |
| Leukemia | 1 |
| Leukemia, Lymphoid | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.